As of 2026-03-21, the Intrinsic Value of XBiotech Inc (XBIT) is -7.47 USD. This XBIT valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.39 USD, the upside of XBiotech Inc is -412.47%.
Based on its market price of 2.39 USD and our intrinsic valuation, XBiotech Inc (XBIT) is overvalued by 412.47%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -7.47 - -7.47 | -7.47 | -412.47% |
| P/E | (25.45) - (30.89) | (27.63) | -1256.1% |
| DDM - Stable | (10.94) - (42.51) | (26.73) | -1218.3% |
| DDM - Multi | (7.88) - (25.31) | (12.20) | -610.6% |
| Market Cap (mil) | 72.87 |
| Beta | 1.39 |
| Outstanding shares (mil) | 30.49 |
| Enterprise Value (mil) | -52.68 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.36% |
| Cost of Debt | 5.00% |
| WACC | 9.67% |